You are here

major depression

J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety

J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety

Endpoints

major depression

Flag link:

Costs Of Treating Those With Diagnosed Depression Eclipses $10,000

Costs Of Treating Those With Diagnosed Depression Eclipses $10,000

Forbes

major depression

healthcare costs

Flag link:

With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine

With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine

Endpoints

major depression

Flag link:

JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

CP Wire

major depression

Flag link:

JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study

major depression

Flag link:

J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results

J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results

Endpoints

major depression

Flag link:

Depression Drug That Works in One Day Passes Key Test

Depression Drug That Works in One Day Passes Key Test

Forbes

major depression

Flag link: